European Commission approves Roche ’s tocilizumab to treat giant cell arteritis

Roche ’s Actemra / RoActemra (tocilizumab) has received approval from the European Commission (EC) to treat giant cell arteritis (GCA).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Actemra